Formulation development of sustained-release hydrophilic matrix tablets of Zileuton

Pharmaceutical Development and Technology

Volumn 2, Issue 3, 1997, Pages 197-204

  Qiu, Yihong ^a   Hui, Ho Wah ^a   Cheskin, Howard ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

5 lipoxygenase inhibitor; In vitro release; Matrix formulation; Sustained release; Zileuton

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; ZILEUTON;

ARTICLE; ASTHMA; DRUG BIOAVAILABILITY; DRUG COST; DRUG DELIVERY SYSTEM; DRUG GRANULATION; DRUG SOLUBILITY; MATRIX TABLET; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION;

EID: 0031393690     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459709031439     Document Type: Article

References (12)

1. Y. Qiu, H. Cheskin, J. Briskin, and K. Engh, Sustained-release hydrophilic matrix tablets of zileuton: formulation and in vitro/in vivo studies, J. Control. Release, 45, 249-256 (1997).
2. J. L. Ford, M. H. Rubinstein, F. McCaul, J. E. Hogan, and P. J. Edgar, Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets, Int. J. Pharm., 40, 223-234 (1987).
3. K Mitchell, J. L. Ford, D. J. Armstrong, et al., The influence of drugs on the properties of gels and swelling characteristics of matrices containing methylcellulose or hydroxypropylmethylcellulose., Int. J. Pharm., 100, 165-173 (1993).
4. J. E. Hogan, Hydroxypropylmethylcellulose sustained release technology, Drug Dev. Ind. Pharm., 15(6&7), 975-999 (1989).
5. N. Sarisuta and P. Mahahpunt, Effects of compression force and types of fillers on release of diclofenac sodium from matrix tablets, Drug Dev. Ind. Pharm., 20(6), 1049-1061 (1994).
6. Technical Information, Manual # 198-1029-1295X GW. Dow Chemical Company, Midland, Michigan, 1995, p. 25.
7. S. Nilsson, Interactions between water-soluble cellulose derivatives and surfactants. 1. The HPMC/SDS/water system, Macromolecules, 28, 7837-7844 (1995).
8. J. E. Lofroth, L. Johansson, A.C. Norman, and K. Wettstrom, Interactions between surfactants and polymers. I: HPMC, Progr. Colloid. Polym. Sci., 84, 73-77 (1991).
9. J. L. Johnson, J. Holinej, and M. D. Williams, Influence of ionic strength on matrix integrity and drug release from hydroxypropyl cellulose compacts, Int. J. Pharm., 90, 151-159 (1993).
10. T. T. Kararli, Composition of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm. Drug Dispos., 16, 351-380 (1995).
11. W. H. Pirkle and T. C. Pochapsky, Considerations of chiral recognition relevant to the liquid chromatographic separation of enantiomers, Chem. Rev., 89, 347-362 (1989).
12. J. B. Dressman and K. Yamada, Animal models for oral drug absorption, in Pharmaceutical Bioequivalence, (P. G. Welling, F. L. S. Tse, and S. V. Dighe, eds.), Marcel Dekker, Inc., New York, 1991, pp. 235-266.